Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy

• Josué Rakotonjanahary ,

  Contributed equally to this work with: Josué Rakotonjanahary, Emilie De Carli

  * E-mail: JoRakotonjanahary@chu-angers.fr

  Affiliations Department of Pediatric Oncology, University Hospital, Angers, France, INSERM CIE5 Robert Debre Hospital, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Sorbonne Paris Cité, Paris, France

  ⨯
• Emilie De Carli ,

  Contributed equally to this work with: Josué Rakotonjanahary, Emilie De Carli

  Affiliation Department of Pediatric Oncology, University Hospital, Angers, France

  ⨯
• Matthieu Delion,

  Affiliation Department of Neurosurgery, University Hospital, Angers, France

  ⨯
• Chantal Kalifa,

  Affiliation Department of Pediatric and Adolescent Oncology, Gustave Roussy Institute, Villejuif, France

  ⨯
• Jacques Grill,

  Affiliation Department of Pediatric and Adolescent Oncology, Gustave Roussy Institute, Villejuif, France

  ⨯
• François Doz,

  Affiliation Department of Pediatric Oncology, Curie Institute and University Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Pierre Leblond,

  Affiliation Department of Pediatric Oncology, Oscar Lambret Center, Lille, France

  ⨯
• Anne-Isabelle Bertozzi,

  Affiliation Department of Pediatric Oncology, University Hospital, Toulouse, France

  ⨯
• Xavier Rialland,

  Affiliation Department of Pediatric Oncology, University Hospital, Angers, France

  ⨯
• Brain Tumor Committee of SFCE

  ¶Membership of the Brain Tumor Committee of SFCE is listed in the Acknowledgments.

  ⨯